TransGenRx, Inc.
Baton Rouge, LA, US· latest recorded location
TransGenRx, Inc. is named on 4 US grants and 6 published applications in this corpus. Its most frequent classification is C12N (Microorganisms or enzymes).
- Granted patents
- 4
- Published applications
- 6
- Inventors
- 5
- Granted in 2026 so far
- 0
- Most recent grant
- 9 Oct 2012
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 2 |
| 2011 | 1 | 1 |
| 2012 | 2 | 1 |
By publication year.
Technology areas
Share of 10 documents
- C12NMicroorganisms or enzymes10
- A61KMedicines and medical preparations9
- A01KAnimal husbandry5
- A61PTherapeutic uses of medicines5
- A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for4
- A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or4
- C07KPeptides4
- Y02ATechnologies for adaptation to climate change2
Recent patents
- Administration of transposon-based vectors to reproductive organs9 Oct 2012US 8,283,518 B2
- Gene therapy using transposon-based vectors7 Aug 2012US 8,236,294 B2
- Gene therapy using transposon-based vectors6 Dec 2011US 8,071,364 B2
- Gene regulation in transgenic animals using a transposon-based vector5 May 2009US 7,527,966 B2
- Gene Therapy Using Transposon-Based Vectors22 Nov 2012US 2012/0297493 A1
- Gene Therapy Using Transposon-Based Vectors30 Jun 2011US 2011/0162096 A1
- Production of Proteins Using Transposon-Based Vectors14 Oct 2010US 2010/0261227 A1
- Gene therapy using transposon-based vectors5 Aug 2010US 2010/0199366 A1
- Administration of transposon-based vectors to reproductive organs25 Sep 2008US 2008/0235815 A1
Most cited
By later US patents
- Gene therapy using transposon-based vectors11US 8,071,364 B22011
- Gene regulation in transgenic animals using a transposon-based vector10US 7,527,966 B22009
- Gene therapy using transposon-based vectors10US 8,236,294 B22012
- Administration of transposon-based vectors to reproductive organs5US 8,283,518 B22012